Qube Research & Technologies (QRT)’s CVS Health CVS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.9M	Buy	173,400 +20,300	+13%	+$1.81M	0.02%	966
2026 Q1	$11M	Sell	153,100 -303,100	-66%	-$23.3M	0.01%	1222
2025 Q4	$36.2M	Buy	456,200 +103,800	+29%	+$8.18M	0.04%	635
2025 Q3	$26.6M	Buy	352,400 +89,300	+34%	+$6.12M	0.03%	759
2025 Q2	$18.1M	Sell	263,100 -146,900	-36%	-$9.63M	0.02%	940
2025 Q1	$27.8M	Buy	410,000 +292,100	+248%	+$17.5M	0.03%	605
2024 Q4	$5.29M	Buy	117,900 +73,400	+165%	+$4.12M	0.01%	1461
2024 Q3	$2.8M	Sell	44,500 -31,500	-41%	-$1.84M	﹤0.01%	1626
2024 Q2	$4.49M	Buy	76,000 +57,900	+320%	+$3.62M	0.01%	1304
2024 Q1	$1.44M	Sell	18,100 -7,800	-30%	-$596K	﹤0.01%	1932
2023 Q4	$2.05M	Buy	+25,900	New	+$1.84M	﹤0.01%	1511

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CVS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its CVS Health (CVS) stake by 47% in Q2 2026, selling an estimated $89.5M and leaving 1,147,850 shares worth $119M. The position accounts for 0.11% of the portfolio, ranked #235.

Qube Research & Technologies (QRT) first reported a position in CVS in Q1 2018 and has held it in 26 quarters since. The position peaked at $154M in Q1 2026. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Qube Research & Technologies (QRT) held 1,147,850 shares of CVS Health worth $119M as of Q2 2026.
Qube Research & Technologies (QRT) sold 1,002,516 CVS Health shares in Q2 2026, an estimated $89.5M.
CVS Health made up 0.11% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #235 holding.
Qube Research & Technologies (QRT) first reported a position in CVS Health in Q1 2018 and has held it in 26 quarters since.
Qube Research & Technologies (QRT)'s CVS Health position peaked at $154M in Q1 2026.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.